NanoSyrinx in Parliament

Our Founder and CEO, Joe Healey, was invited by the Parliamentary and Scientific Committee (P&SC – https://www.scienceinparliament.org.uk/) to discuss the future and potential of Synthetic Biology for the UK and for human health.

The UK has a stated (and laudable) ambition to become a “Scientific Superpower”, and Synthetic Biology is intimately tied to that vision. It was a cornerstone of the industrial strategy under previous leadership, and is still very much at the forefront of current science policy thinking.

The panel, was organised by SynBioBeta (the largest synthetic biology community and advocacy group) and Bit.Bio (a UK ‘cell programming’ company) with the P&SC. Whilst the focus of the discussion was particularly what Synthetic Biology could offer for human health, a wide range of topics were covered including synbio for sustainability and Net Zero, as well as a discussion about what the UK entrepreneurship ecosystem needs in order to thrive.


The panel was chaired by Stephen Metcalfe MP (South Basildon and East Thurrock), and the speakers included (pictured left to right above):

  • Mark Kotter, CEO of Bit.bio

  • Sara Holland, Patent attorney at Potter Clarkson specialising in synbio IP

  • Stephen Metcalfe MP, chair of the session

  • Fiona Mischel, Director of Human Health content at SynBioBeta

  • Joe Healey, Founder and CEO of NanoSyrinx

Read more news

NanoSyrinx CEO Joe Healey appointed to DSIT’s Engineering Biology Steering Group

In 2023, the UK Government published the “National Vision for Engineering Biology”. The report highlighted the ambitions of the UK to be a world leader in the Engineering Biology (a.k.a. Synthetic Biology) sector, and described how £2BN would be put to work over the next decade, cementing the UK’s position at the front of the […]

Read more

NanoSyrinx at Number 10

Our CEO Joe Healey was invited to Number 10 this week, to discuss the future of Engineering Biology in the UK as part of a networking and investment breakfast. Synthetic biology or “Engineering Biology” has been highlighted as one of the five key technology areas for the UK’s future economy. Understanding how best to incubate, […]

Read more

JPM week 2024: NanoSyrinx highlighted in GEN

NanoSyrinx CEO Joe Healey, and CBO James Lapworth attended the JP Morgan Healthcare conference in San Francisco last week. Among a great week of meetings with collaborators, investors and partners, they sat down with Jonathan Grinstein PhD, a writer for GEN Edge, and spoke about the journey the company had been on and the outlook […]

Read more